Sarepta Shares Jump After FDA Approves Updated Elevidys Label

benzinga.com/news/fda/25/11/48883507/sarepta-shares-jump-after-fda-approves-updated-elevidys-label

Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock jumped on Friday after the FDA issued a new boxed warning for Elevidys. The updated approval follows recent reports of fatal liver injury in non-ambulatory pediatric patients who received the gene therapy.
SRPT stock is moving. Watch the…

This story appeared on benzinga.com, 2025-11-14 22:48:37.
The Entire Business World on a Single Page. Free to Use →